Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 E Morehead St
Charlotte, NC 28202Phone+1 704-334-7800Fax+1 704-414-7512
Education & Training
Johns Hopkins UniversityFellowship, Vascular and Interventional Radiology, 2004 - 2005
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 2000 - 2004
New York Presbyterian HospitalInternship, Transitional Year, 1999 - 2000- Johns Hopkins University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - Present
NC State Medical License 2005 - 2025
SC State Medical License 2005 - 2025
MD State Medical License 2004 - 2005- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 204 citationsFirst-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and ...Harpreet Wasan, Peter Gibbs, Navesh K Sharma, Julien Taieb, Volker Heinemann
The Lancet. Oncology. 2017-09-01 - 13 citationsUpdated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal ...Andrew Kennedy, Michael Cohn, Douglas M Coldwell, Alain Drooz, Eduardo Ehrenwald
Journal of Gastrointestinal Oncology. 2017-08-01 - 14 citationsLong-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (...Thomas Y Wong, Kevin S Zhang, Ripal T Gandhi, Zachary S Collins, Ryan O'Hara
BMC Cancer. 2022-03-01
Press Mentions
ABK Biomedical Announces First Patient Treated in Its Multi-Center Pivotal Study of Eye90 Microspheres® in Hepatocellular CarcinomaOctober 25th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
